HYPERION DEFI, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
HYPERION DEFI, INC. (HYPD) had Lessee, Operating Lease, Liability, to be Paid, Year One of $561.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-03-30
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $561.00K.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $675.40K.
- 2024-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $183.09K.
- 2024-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $364.93K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One | Lessee, Operating Lease, Liability, to be Paid, Year One as first filed |
|---|---|---|
| 2025-12-31 | $561.00K 10-K · filed 2026-03-30 | |
| 2024-12-31 | $675.40K 10-K · filed 2025-04-15 | |
| 2024-09-30 | $183.09K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $364.93K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $542.72K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $660.92K 10-K · filed 2024-03-18 | $480.98M 10-Q · filed 2023-05-12 |
| 2023-09-30 | $660.92K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $660.92K 10-Q · filed 2023-08-11 | |
| 2022-12-31 | $588.18K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |